Global Anti-Infective Drugs Market Report 2022 – Market Forecast, Trends And Strategies

7 Mar, 2022

The global anti-infective drugs market size is expected to decline from $220.00 billion in 2021 to $246.80 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The change in the anti-infective drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The anti-infective drugs market is expected to reach $614.29 billion in 2026 at a CAGR of 25.6%.

What is the Global Anti-Infective Drugs Market?

The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections.

Get a Sample of the global anti-infective drugs market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3604&&type=smp

What drives the Global Anti-Infective Drugs Market?

The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the anti-infective drugs market in the forecast period.

Get the full global anti-infective drugs industry report here:

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report

Global Anti-Infective Drugs Market Segments
The global anti-infective drugs market is segmented:
By Type: Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
By Route of Administration: Oral, Parenteral, Others
By Drug Classification: Branded Drugs, Generic Drugs
By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
By Geography: The regions covered in the anti-infective drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Anti-Infective Drugs Global Market Report 2022provides market size and growth forecasts for the global anti-infective drugs market, global anti-infective drugs market share, anti-infective drugs market segments and geographies, anti-infective drugs market competitive landscape including leading competitors’ revenues, profiles and market shares. The anti-infective drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Anti-Infective Drugs Industry Playersinclude Gilead Sciences, GlaxoSmithKline, Merck & Co, Johnson & Johnson, Pfizer Inc., AbbVie, Bayer AG, Mylan N.V., Shionogi and F. Hoffmann-La Roche Ltd. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.